Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33M
-
Number of holders
-
5
-
Total 13F shares, excl. options
-
746K
-
Shares change
-
+473K
-
Total reported value, excl. options
-
$70.9M
-
Value change
-
+$44.9M
-
Number of buys
-
2
-
Number of sells
-
-1
-
Price
-
$95.06
Significant Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) as of Q4 2023
5 filings reported holding AMED - AMEDISYS INC - Common Stock, par value $0.001 per share as of Q4 2023.
AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) has 5 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 746K shares
of 33M outstanding shares and own 2.26% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.22M shares), BlackRock Inc. (2.96M shares), FIL Ltd (1.31M shares), ALPINE ASSOCIATES MANAGEMENT INC. (1.27M shares), MILLENNIUM MANAGEMENT LLC (1.19M shares), STATE STREET CORP (933K shares), Westchester Capital Management, LLC (879K shares), MACKENZIE FINANCIAL CORP (878K shares), Park West Asset Management LLC (812K shares), and Pentwater Capital Management LP (780K shares).
This table shows the top 5 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.